Progresses in Nano-Enabled Platforms for the Treatment of Vaginal Disorders

Abstract

Background: The most common vaginal disorders are within the uterus. According to the latest statistics, vaginal disorders occur in 50% to 60% of females. Although curative treatments rely on surgical therapy, still first-line treatment is a noninvasive drug. Conventional therapies are available in the oral and parenteral route, leading to nonspecific targeting, which can cause dose-related side effects. Vaginal disorders are localized uterine disorders in which intrauterine delivery via the vaginal site is deemed the preferable route to mitigate clinical drug delivery limitations. Objective: This study emphasizes the progress of site-specific and controlled delivery of therapeutics in the treatment of vaginal disorders and systemic adverse effects as well as the therapeutic efficacy Methods: Related research reports and patents associated with topics are collected, utilized, and summarized the key findings. Result: The comprehensive literature study and patents like (US 9393216 B2), (JP6672370B2), and (WO2018041268A1) indicated that nanocarriers are effective above traditional treatments and have some significant efficacy with novelty. Conclusion: Nowadays, site-specific and controlled delivery of therapeutics for the treatment of vaginal disorders is essential to prevent systemic adverse effects and therapeutic efficacy would be more effective. Nanocarriers have therefore been used to bypass the problems associated with traditional delivery systems for the vaginal disorder.

The Evolving Landscape of Colonoscopy: Recent Developments and Complication Management

“…Additionally, colonoscopy has the capability to detect cancers at an early stage, increasing the likelihood of successful treatment compared to those found in more advanced stages. Given its ability to detect and remove polyps before they progress to cancer, colonoscopy appears to be an ideal screening tool [43,44].…”

Recent Advances in Nanotechnology-Based Drug Delivery Systems for the Diagnosis and Treatment of Reproductive Disorders

“…Additionally, ongoing research is exploring the use of nanomaterials for diagnostic purposes, such as imaging and sensing techniques, 7 further expanding their potential in the field of medicine. 8 Nanotechnology holds promise to treat many chronic diseases, which include cardiovascular, 9 neurological, 10 gastrointestinal, 11 autoimmune inflammatory, 12 infectious, 13 and reproductive diseases, 14 as well as various types of cancer. 15 With the help of nanoscience, reproductive assistive technology has revolutionized the field of fertility treatments, and scientists have been able to develop innovative methods that improve the success rates of procedures such as in vitro fertilization (IVF) and sperm selection by utilizing nano-technology.…”

“…Nanomedicine offers the potential to revolutionize treatment options by delivering drugs directly to affected cells or tissues, improving therapeutic outcomes, and reducing systemic toxicity. Additionally, ongoing research is exploring the use of nanomaterials for diagnostic purposes, such as imaging and sensing techniques, further expanding their potential in the field of medicine . Nanotechnology holds promise to treat many chronic diseases, which include cardiovascular, neurological, gastrointestinal, autoimmune inflammatory, infectious, and reproductive diseases, as well as various types of cancer …”